[Mechanism of HCV cell entry mediated by envelope and receptor proteins].
Nishioka
Tomoji
T
Department of Medicine and Molecular Science, Graduate School of Biomedical Sciences, Hiroshima University.
Chayama
Kazuaki
K
D000818:Animals; D015703:Antigens, CD / Q000502:physiology; D015815:Cell Adhesion Molecules / Q000502:physiology; D016174:Hepacivirus / Q000472:pathogenicity*; D006526:Hepatitis C / Q000209:etiology; D006801:Humans; D037181:Lectins, C-Type / Q000502:physiology; D011956:Receptors, Cell Surface / Q000502:physiology; D011971:Receptors, Immunologic / Q000502:physiology; D011973:Receptors, LDL / Q000502:physiology; D051116:Receptors, Scavenger; D011991:Receptors, Virus / Q000502:physiology; D060225:Tetraspanin 28; D014759:Viral Envelope Proteins / Q000502:physiology*
D015703:Antigens, CD; C554798:CD81 protein, human; C433029:CLEC4M protein, human; D015815:Cell Adhesion Molecules; C087035:E1 protein, Hepatitis C virus; D037181:Lectins, C-Type; D011956:Receptors, Cell Surface; D011971:Receptors, Immunologic; D011973:Receptors, LDL; D051116:Receptors, Scavenger; D011991:Receptors, Virus; D060225:Tetraspanin 28; D014759:Viral Envelope Proteins; C091015:glycoprotein E2, Hepatitis C virus